Results 191 to 200 of about 1,831,004 (275)

The use of H-index to assess research priorities in poultry diseases. [PDF]

Poult Sci, 2020
Bertran K, Cortey M, Díaz I.
europepmc   +1 more source

Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids

Molecular Oncology, EarlyView.
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici, Soheil Akbari, Ceyda Caliskan, Canan Celiker, Ozden Oz, Leman Binokay, Gökhan Karakulah, Serif Senturk, Esra Erdal   +8 more
wiley   +1 more source

Assessment of h-index and associated demographic and academic parameters for academic hematologists in Canada. [PDF]

Front Med (Lausanne)
Ordaz DJG, Roy J, Ahmad I, Kaouache M, Ramchatesingh B, Whitelaw S, Nikonova A, Bredeson C, Litvinov IV.   +8 more
europepmc   +1 more source

The k-index is introduced to replace the h-index to evaluate better the scientific excellence of individuals. [PDF]

Heliyon, 2020
Kaptay G.
europepmc   +1 more source

Mathematical theory of the h‐ and g‐index in case of fractional counting of authorship

, 2008
Leo Egghe
openalex   +2 more sources

How Good is the H-Index?

The h-index has become a widely used metric for evaluating the productivity and citation impact of researchers. Introduced by physicist Jorge E. Hirsch in 2005, the h-index measures both the quantity (number of publications) and quality (citations) of a researcher's output. While it has gained popularity for its simplicity and practicality, the h-index
openaire   +2 more sources

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

The H-index is an unreliable research metric for evaluating the publication impact of experimental scientists. [PDF]

Front Res Metr Anal
Akhtar MK.
europepmc   +1 more source

Part H, Brachiopoda (Revised), vol. 5, References and Index

, 2006
Alwyn Williams
openalex   +2 more sources

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source